Upstream Bio (UPB) Change in Acquisitions & Divestments (2023 - 2026)

Upstream Bio's Change in Acquisitions & Divestments history runs 4 years deep, the most recent figure standing at $56.8 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments rose 7.87% year-over-year to $56.8 million; the TTM figure through Mar 2026 stood at $296.7 million (up 20.1% YoY), while the FY2025 annual figure was $292.6 million, up 26.3% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $56.8 million, down from $97.3 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $97.3 million in Q4 2025, with the low at $29.6 million in Q4 2023.
• The 4-year median for Change in Acquisitions & Divestments is $63.4 million (2025), against an average of $61.1 million.
• The sharpest annual moves came in 2024 and 2025: Change in Acquisitions & Divestments surged 185.25% in 2024, then declined 3.23% in 2025.
• Upstream Bio's Change in Acquisitions & Divestments stood at $29.6 million in 2023, then soared by 185.25% to $84.3 million in 2024, then gained by 15.39% to $97.3 million in 2025, then plunged by 41.59% to $56.8 million in 2026.
• Business Quant data shows UPB's Change in Acquisitions & Divestments at $56.8 million in Q1 2026, $97.3 million in Q4 2025, and $72.7 million in Q3 2025.